Tachykinin (NK.sub.2) antagonists
US5554644A · kind A · utility
3Cited by
2References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 8, 1994 |
| Grant date | Sep 10, 1996 |
| Priority date | — |
| Expiry date | Jun 8, 2014 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The compounds of the instant invention are ligands for the NK.sub.2 receptor. The compounds are modified at the C-terminus to provide various amide isostere derivatives expected to be useful in treating obesity, anxiety, gastrointestinal ulcers, pain, stroke, and inflammation. Pharmaceutical compositions and methods of using the compounds are also included.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.